Showing results (11-20 of 25,446) with videos related to
Sort By:
Pageof 2,545
American Journal of Clinical Oncology|August 16, 2012
Submandibular gland-sparing intensity-modulated radiotherapyWilliam M Mendenhall, Charles M Mendenhall, Nancy P MendenhallAmerican Journal of Otolaryngology|November 11, 2003
Solitary plasmacytoma of bone and soft tissuesWilliam M Mendenhall, Charles M Mendenhall, Nancy Price MendenhallAmerican Journal of Clinical Oncology|December 20, 2007
Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of FloridaBhishamjit S Chera, Kenneth Olivier, Christopher G Morris, et al.Leukemia & Lymphoma|February 12, 2015
Proton therapy in the management of non-Hodgkin lymphomaSuzanne Sachsman, Stella Flampouri, Zuofeng Li, et al.Seminars in Radiation Oncology|July 1, 1996
Diagnostic Procedures and Guidelines for the Evaluation and Follow-up of Hodgkin's DiseaseMendenhallAmerican Journal of Clinical Oncology|June 1, 1994
The role of prognostic factors in treatment selection for early-stage Hodgkin's diseaseN P Mendenhall, A B Cantor, D M Barré, et al.American Journal of Clinical Oncology|April 2, 2005
A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphomaBradley J G Larson, John M Waples, Annette Pusateri, et al.American Journal of Clinical Oncology|May 13, 2009
Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ringDaniel T Chang, Nancy P Mendenhall, James W Lynch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disordersLucio N Gordan, William B Grow, Annette Pusateri, et al.Oncology (Williston Park, N.Y.)|June 27, 2012
Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapyBradford S Hoppe, Stella Flampouri, James Lynch, et al.Pageof 2,545